Related Experiment Video
Updated: Jan 25, 2026

Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues
Published on: May 30, 2025
LRRC15 in tumorigenesis, progression, and therapy
1School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China; Department of Interventional Medicine, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201999, China.
Abstract:
Leucine-rich repeat-containing protein 15 (LRRC15), a transmembrane protein, has been closely associated with malignant phenotypes, therapeutic resistance, and immune evasion in various solid tumors since its initial identification as a tumor-associated antigen in 2003. This review systematically summarizes the molecular characteristics of LRRC15, its regulatory functions in the tumor microenvironment (TME), and its potential as a diagnostic biomarker and therapeutic target. By integrating recent advancements in genomics, proteomics, single-cell sequencing, and clinical translational research, this article comprehensively elucidates the multifaceted mechanisms of LRRC15 in tumor initiation, metastasis, immune regulation, and therapy resistance. It also discusses current research limitations and future directions, aiming to provide multidimensional theoretical and practical insights for precision oncology.
More Related Videos
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Gene Therapy
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Group Therapy
Psychodynamic Therapy
Humanistic Therapy

